DUORESP® SPIROMAX® DRY POWDER FOR INHALATION 160 MCG/4.5 MCG
Product details
Registration number: SIN16056P
Classification: Prescription Only
Active ingredients:
- Budesonide (micronised)
- Formoterol fumarate dihydrate (micronised)
Strength:
- 160 mcg / inhalation
- 4.5 mcg / inhalation
Dosage form: POWDER, METERED
Route: RESPIRATORY (INHALATION)
Registrant: TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.
ATC code: R03AK07
HSA approval date: 7 December 2020
Manufacturer(s): Norton (Waterford) Limited
Manufacturing country/countries: IRELAND
What are the HSA registration number and classification for DUORESP® SPIROMAX® DRY POWDER FOR INHALATION 160 MCG/4.5 MCG?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN16056P
Classification: Prescription Only
What active ingredients and strength are recorded for DUORESP® SPIROMAX® DRY POWDER FOR INHALATION 160 MCG/4.5 MCG?
According to the HSA dataset updated 7 August 2026:
Active ingredients:
- Budesonide (micronised)
- Formoterol fumarate dihydrate (micronised)
Strength:
- 160 mcg / inhalation
- 4.5 mcg / inhalation
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for DUORESP® SPIROMAX® DRY POWDER FOR INHALATION 160 MCG/4.5 MCG?
According to the HSA dataset updated 7 August 2026:
Dosage form: POWDER, METERED
Route: RESPIRATORY (INHALATION)
Who is the recorded registrant for DUORESP® SPIROMAX® DRY POWDER FOR INHALATION 160 MCG/4.5 MCG?
According to the HSA dataset updated 7 August 2026:
Registrant: TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.
Which manufacturers and countries are listed for DUORESP® SPIROMAX® DRY POWDER FOR INHALATION 160 MCG/4.5 MCG?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s): Norton (Waterford) Limited
Manufacturing country/countries: IRELAND
Where can I look up DUORESP® SPIROMAX® DRY POWDER FOR INHALATION 160 MCG/4.5 MCG in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN16056P or the exact product name DUORESP® SPIROMAX® DRY POWDER FOR INHALATION 160 MCG/4.5 MCG. The general register link does not preselect this product.
What are the source dates for this DUORESP® SPIROMAX® DRY POWDER FOR INHALATION 160 MCG/4.5 MCG record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this DUORESP® SPIROMAX® DRY POWDER FOR INHALATION 160 MCG/4.5 MCG record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN16056P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)